期刊
CHEMMEDCHEM
卷 7, 期 3, 页码 464-470出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201100538
关键词
coumarins; heterocycles; molecular modeling; monoamine oxidase; perkin reaction
资金
- Xunta de Galicia [09CSA030203PR, PGI-DIT07PXIB, 10PXIB203303PR]
- Spanish Ministerio de Sanidad y Consumo [FIS PS09/00501]
- MIUR
- Cagliari University
- CINMPIS
- FIRB
- Fundacao de Ciencia e Tecnologia [SFRH/BD/61262/2009]
Neurodegenerative disorders are becoming more prevalent given the increase in the aging population. This has inspired active research in the development of new drugs that could mark an important advance in the treatment of complex diseases such as Alzheimer's and Parkinson's. With the aim of finding new MAO-B-selective inhibitors, we report the synthesis, in vitro evaluation, and docking simulation of a new series of 3-arylcoumarins variously substituted at the 8-position. Most of the studied compounds show high affinity and selectivity for the hMAO-B isoform, with IC50 values in the low micro- to nanomolar range. Some of them have greater hMAO-B inhibitory activity and selectivity than the reference compound, selegiline. Compounds 7 and 8 are the most active of this series, with compound 8 being fivefold more potent against MAO-B and severalfold more selective than selegiline. Docking experiments were carried out with hMAO-B crystal structures, providing new information about the enzymeinhibitor interaction and the potential therapeutic application of the new 8-substituted 3-arylcoumarins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据